Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping

Investigative Radiology

Volumn 49, Issue 7, 2014, Pages 498-504

  Tan, Huan ^a   Liu, Tian ^b   Wu, Ying ^c,d   Thacker, Jon ^e   Shenkar, Robert ^a   Mikati, Abdul Ghani ^a   Shi, Changbin ^a   Dykstra, Conner ^f   Wang, Yi ^g,h   Prasad, Pottumarthi V ^c,d   Edelman, Robert R ^c,i   Awad, Issam A ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b Medimagemetric LLC   (United States)

^c NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e Northwestern University   (United States)

^f NORTHWESTERN UNIVERSITY   (United States)

^g WEILL CORNELL MEDICAL COLLEGE   (United States)

^h School of Operations Research and Industrial Engineering   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

Author keywords

brain iron; cerebral cavernous malformation; imaging biomarker; quantitative susceptibility mapping

Indexed keywords

FERUMOXYTOL; IRON; BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; BRAIN MAPPING; BRAIN REGION; CAVERNOUS HEMANGIOMA; CHEMICAL ANALYSIS; CLINICAL ARTICLE; EX VIVO STUDY; FEMALE; HUMAN; IMAGE QUALITY; IN VIVO STUDY; MAGNETISM; MALE; MASS SPECTROMETRY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE SUSCEPTIBILITY MAPPING; SUSCEPTIBILITY WEIGHTED IMAGING; VALIDATION STUDY; BRAIN HEMANGIOMA; BRAIN TUMOR; CHEMISTRY; COMPUTER ASSISTED DIAGNOSIS; EVALUATION STUDY; MIDDLE AGED; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOMARKERS; BRAIN NEOPLASMS; FEMALE; HEMANGIOMA, CAVERNOUS, CENTRAL NERVOUS SYSTEM; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84902172723     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000043     Document Type: Article

References (39)

1. Rigamonti D, Hadley MN, Drayer BP, et al. Cerebral cavernous malformations: incidence and familial occurrence. N Engl J Med. 1988;319:343-347.
2. Robinson JR, Awad IA, Little JR Natural history of the cavernous angioma. J Neurosurg. 1991;75:709-714.
3. Zabramski JM, Wascher TM, Spetzler RF, et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80:422-432. (Pubitemid 24073002)
4. Robinson JR Jr, Awad IA, Magdinec M, et al. Factors predisposing to clinical disability in patients with cavernous malformations of the brain. Neurosurgery. 1993;32:730-735; discussion 5-6.
5. Robinson JR Jr, Awad IA, Masaryk TJ, et al. Pathological heterogeneity of angiographically occult vascular malformations of the brain. Neurosurgery. 1993;33:547-554; discussion 54-55.
6. McDonald DA, Shenkar R, Shi C, et al. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease. Hum Mol Genet. 2011;20:211-222.
7. McDonald DA, Shi C, Shenkar R, et al. Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012;43:571-574.
8. de Champfleur NM, Langlois C, Ankenbrandt WJ, et al. Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibilityweighted imaging. Neurosurgery. 2011;68:641-647; discussion 7-8.
9. Haacke EM. Susceptibility weighted imaging (SWI). Z Med Phys. 2006;16:237. (Pubitemid 46032052)
10. Rossi M, Ruottinen H, Elovaara I, et al. Brain iron deposition and sequence characteristics in Parkinsonism: comparison of SWI, T(2), maps, T(2)- weighted-, and FLAIR-SPACE. Invest Radiol. 2010;45:795-802.
11. de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using Bayesian regularization: validation and application to brain imaging. Magn Reson Med. 2010;63:194-206.
12. Haacke EM, Ayaz M, Khan A, et al. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J Magn Reson Imaging. 2007;26:256-264. (Pubitemid 47257722)
13. Liu T, Liu J, de Rochefort L, et al. Morphology enabled dipole inversion (MEDI) from a single-Angle acquisition: comparison with COSMOS in human brain imaging. Magn Reson Med. 2011;66:777-783.
14. Schweser F, Deistung A, Lehr BW, et al. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med Phys. 2010;37:5165-5178.
15. Marques JP, Bowtell R. Application of a Fourier-based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts Magn Reson Part B Magn Reson Eng. 2005;25B:65-78. (Pubitemid 40776540)
16. Liu T, Khalidov I, de Rochefort L, et al. A novel background field removal method for MRI using projection onto dipole fields (PDF). NMR Biomed. 2011;24:1129-1136.
17. Liu T, Wisnieff C, Lou M, et al. Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping. Magn Reson Med. 2013;69:467-476.
18. Schweser F, Deistung A, Lehr BW, et al. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage. 2011;54:2789-2807.
19. Liu T, Surapaneni K, Lou M, et al. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology. 2012;262:269-278.
20. Langkammer C, Liu T, Khalil M, et al. Quantitative susceptibility mapping in multiple sclerosis. Radiology. 2013;267:551-559.
21. Deistung A, Schweser F, Wiestler B, et al. Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PLoS One. 2013;8(3):e57924.
22. Chen W, Zhu W, Kovanlikaya I, et al. Intracranial calcifications and hemorrhages: characterization with quantitative susceptibility mapping. Radiology. 2014;270:496-505.
23. Lotfipour AK, Wharton S, Schwarz ST, et al. High resolution magnetic susceptibility mapping of the substantia nigra in Parkinsons disease. J Magn Reson Imaging. 2012;35:48-55.
24. Fritzsch D, Reiss-Zimmermann M, Trampel R, et al. Seven-Tesla magnetic resonance imaging inWilson disease using quantitative susceptibility mapping for measurement of copper accumulation. Invest Radiol. 2013. Epub 2013 Nov 11.
25. Langkammer C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage. 2012;62:1593-1599.
26. Zheng W, Nichol H, Liu S, et al. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage. 2013;78:68-74.
27. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002;47:1202-1210. (Pubitemid 34587412)
28. Bilgic B, Pfefferbaum A, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage. 2012;59: 2625-2635.
29. Liu T, Spincemaille P, de Rochefort L, et al. Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI. Magn Reson Med. 2009;61:196-204.
30. Barick KC, Aslam M, Lin Y, et al. Novel and efficient MR active aqueous colloidal Fe3O4 nanoassemblies. J Mater Chem. 2009;19:7023-7029.
31. Shenkar R, Venkatasubramanian PN, Wyrwicz AM, et al. Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models. Neurosurgery. 2008;63:790-797; discussion 7-8.
32. Shenkar R, Venkatasubramanian PN, Zhao JC, et al. Advanced magnetic resonance imaging of cerebral cavernous malformations, part I: high-field imaging of excised human lesions. Neurosurgery. 2008;63:782-789; discussion 9.
33. Bradley WG Jr. MR appearance of hemorrhage in the brain. Radiology. 1993;189:15-26. (Pubitemid 23292911)
34. Langkammer C, Krebs N, Goessler W, et al. Quantitative MR imaging of brain iron: a postmortem validation study. Radiology. 2010;257:455-462.
35. Leblanc GG, Golanov E,Awad IA, et al. Biology of vascular malformations of the brain. Stroke. 2009;40:e694-e702.
36. LiW,Wu B, Liu C. Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition. Neuroimage. 2011;55:1645-1656.
37. Yadla S, Jabbour PM, Shenkar R, et al. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus. 2010;29:E4.
38. Pfefferbaum A, Adalsteinsson E, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. Neuroimage. 2009;47:493-500.
39. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem. 1958;3:41-51.